“No one should die of malignant melanoma” - A. Bernard Ackerman, 1985

Skin Cancer
Institute Blog

[6 min watch] Second opinion & clinico-pathologic correlation Part 3: Prof Giuseppe Argenziano

By Skin Cancer Institute |November 24, 2021 posted in skin cancer diagnosis, melanoma, pathology

In this final part of a three-part series, Prof Giuseppe Argenziano discusses the way in which a second opinion by an experienced dermatopathologist can significantly improve the clinical management ...
Read More

[5 min read] Melanoma size not a reliable predictor of invasion | Prof David Wilkinson

By Skin Cancer Institute |November 15, 2021 posted in skin cancer diagnosis, melanoma

This month’s paper is from the SCARD database, and reports on the features of over 600 melanomas diagnosed by almost 30 GPs across Australia.
Read More

[5 min watch] Second opinion & clinico-pathologic correlation Part 2: Prof Giuseppe Argenziano

By Skin Cancer Institute |October 19, 2021 posted in skin cancer diagnosis, melanoma, pathology

In this second part of a four-part series, Prof Giuseppe Argenziano discusses the way in which a second opinion by an experienced dermatopathologist can significantly improve the clinical management ...
Read More

[Online lecture] Recurrent melanocytic naevus vs melanoma

By Skin Cancer Institute |May 11, 2021 posted in skin cancer diagnosis, skin cancer treatment, melanoma

In this online lecture from HealthCert Education, Associate Professor Andreas Blum provides an overview of how the history, clinical features and dermoscopy of a lesion can help differentiate between ...
Read More

Concordance between patient concerns and skin cancer diagnosis

By Skin Cancer Institute |May 11, 2021 posted in Skin Cancer, skin cancer diagnosis, Detection, skin cancer check

This month's research article caught my eye because it is such a simple, yet useful and relevant study. From a single practice in Brisbane, the paper reports on the agreement or not between lesions ...
Read More

Recent Posts